机译:2016年患者诊断早期和明显的原发性髓过敏的影响和ruxolitinib治疗232例患者的展示和结果
St Orsola Malpighi Univ Hosp Inst Hematol L&
A Seragnoli Bologna Italy;
Univ Catania AOU Policlin V Emanuele Div Hematol Catania Italy;
Osped S Eugenio Div Hematol Rome Italy;
Fdn IRCCS Ca Granda Osped Maggiore Policlin Hematol Div Milan Italy;
Univ Brescia ASST Spedali Civili Brescia Dept Clin &
Expt Sci Unit Blood Dis &
Stem Cells;
ASST Monza San Gerardo Hosp Hematol Div Monza Italy;
Univ Verona Sect Hematol Dept Med Verona Italy;
IRCCS AOU San Martino IST Clin Hematol Dept Internal Med DiMI Genoa Italy;
Azienda Osped Bianchi Melacrino Morelli Div Hematol Reggio Di Calabria Italy;
Azienda Sanit Univ Integrata Udine Div Hematol &
BMT Udine Italy;
Citta Salute &
Sci Hosp Div Hematol Turin Italy;
Azienda USL IRCCS Reggio Emilia Dept Hematol Reggio Emilia Italy;
Casa Sollievo Sofferenza Div Hematol San Giovanni Rotondo Italy;
AORMN Hosp Hematol &
Stem Cell Transplant Ctr Pesaro Italy;
Univ Padua Unit Hematol &
Clin Immunol Padua Italy;
Azienda Osped Univ Parma Div Hematol Parma Italy;
Friedrich Schiller Univ Med Ctr Internal Med Hematol &
Oncol 2 Jena Germany;
Univ Ferrara Div Hematol Ferrara Italy;
AUSL Piacenza Div Hematol Piacenza Italy;
St Orsola Malpighi Univ Hosp Inst Hematol L&
A Seragnoli Bologna Italy;
Fdn IRCCS Ca Granda Osped Maggiore Policlin Hematol Div Milan Italy;
Univ Sapienza Div Cellular Biotechnol &
Hematol Rome Italy;
IRCCS AOU San Martino IST Clin Hematol Dept Internal Med DiMI Genoa Italy;
Univ Ferrara Div Hematol Ferrara Italy;
Univ Verona Sect Hematol Dept Med Verona Italy;
St Orsola Malpighi Univ Hosp Inst Hematol L&
A Seragnoli Bologna Italy;
St Orsola Malpighi Univ Hosp Inst Hematol L&
A Seragnoli Bologna Italy;
St Orsola Malpighi Univ Hosp Inst Hematol L&
A Seragnoli Bologna Italy;
Univ Sapienza Div Cellular Biotechnol &
Hematol Rome Italy;
Univ Sapienza Div Cellular Biotechnol &
Hematol Rome Italy;
MYELOFIBROSIS; RUXOLITINIB; EARLY PMF; OVERT PMF;
机译:2016年患者诊断早期和明显的原发性髓过敏的影响和ruxolitinib治疗232例患者的展示和结果
机译:2016年患者诊断早期和明显的原发性髓过敏的影响和ruxolitinib治疗232例患者的展示和结果
机译:199例患者2016年患者的展示和结果诊断早期和明显的原发性髓纤维纤维化治疗Raxolitinib
机译:肾功能不全对初级经皮冠状动脉干预治疗的ST段升高心肌梗死患者30天后的影响
机译:使用原发性骨髓纤维化的高分辨率配对配对测序鉴定和表征新型微改变和明显的细胞遗传学断裂点。
机译:Fedratinib先前用Ruxolitinib治疗的肌纤维纤维病患者提高了骨髓纤维病相关症状和健康相关的生活质量:患有II期雅加达2次试验的患者报告的结果
机译:2016年WHO诊断为纤维前和原发性原发性骨髓纤维化的患者的表现和结果